{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T04:13:25Z","timestamp":1727324005983},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,25]]},"DOI":"10.7759\/cureus.70159","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T13:06:16Z","timestamp":1727269576000},"source":"Crossref","is-referenced-by-count":0,"title":["Unprecedented Haemorrhagic Stroke: A Rare Manifestation of Atypical Haemolytic Syndrome"],"prefix":"10.7759","author":[{"given":"Shahzaib","family":"Fida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sucheta","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2015.07.005","article-title":"An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document","volume":"35","author":"Campistol JM","year":"2015","unstructured":"Campistol JM, Arias M, Ariceta G, et al.. An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document. Nefrologia. 2015, 35:421-47. 10.1016\/j.nefro.2015.07.005","journal-title":"Nefrologia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat C","year":"2011","unstructured":"Loirat C, Fr\u00e9meaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis. 2011, 6:60. 10.1186\/1750-1172-6-60","journal-title":"Orphanet J Rare Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-4039-7","article-title":"Extra-renal manifestations of atypical hemolytic uremic syndrome","volume":"34","author":"Formeck C","year":"2019","unstructured":"Formeck C, Swiatecka-Urban A. Extra-renal manifestations of atypical hemolytic uremic syndrome. Pediatr Nephrol. 2019, 34:1337-48. 10.1007\/s00467-018-4039-7","journal-title":"Pediatr Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-014-0416-x","article-title":"Hemolytic uremic syndrome","volume":"36","author":"Mele C","year":"2014","unstructured":"Mele C, Remuzzi G, Noris M. Hemolytic uremic syndrome. Semin Immunopathol. 2014, 36:399-420. 10.1007\/s00281-014-0416-x","journal-title":"Semin Immunopathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris M","year":"2010","unstructured":"Noris M, Caprioli J, Bresin E, et al.. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol. 2010, 5:1844-59. 10.2215\/CJN.02210310","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ped.12274","article-title":"Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the Joint Committee of the Japanese Society of Nephrology and the Japan Pediatric Society","volume":"56","author":"Sawai T","year":"2014","unstructured":"Sawai T, Nangaku M, Ashida A, et al.. Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the Joint Committee of the Japanese Society of Nephrology and the Japan Pediatric Society. Pediatr Int. 2014, 56:1-5. 10.1111\/ped.12274","journal-title":"Pediatr Int"},{"key":"ref7","unstructured":"Hemolytic Uremic Syndrome. Management and Complications. (2019). https:\/\/www.news-medical.net\/health\/Hemolytic-Uremic-Syndrome-Management-and-Complications.aspx."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris M","year":"2009","unstructured":"Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med. 2009, 361:1676-87. 10.1056\/NEJMra0902814","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-016-0420-6","article-title":"Turkish pediatric atypical hemolytic uremic syndrome registry: Initial analysis of 146 patients","volume":"18","author":"Besbas N","year":"2017","unstructured":"Besbas N, Gulhan B, Soylemezoglu O, Ozcakar ZB, Korkmaz E, Hayran M, Ozaltin F. Turkish pediatric atypical hemolytic uremic syndrome registry: Initial analysis of 146 patients. BMC Nephrol. 2017, 18:6. 10.1186\/s12882-016-0420-6","journal-title":"BMC Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/adc.76.6.518","article-title":"Heterogeneity of atypical haemolytic uraemic syndromes","volume":"76","author":"Neuhaus TJ","year":"1997","unstructured":"Neuhaus TJ, Calonder S, Leumann EP. Heterogeneity of atypical haemolytic uraemic syndromes. Arch Dis Child. 1997, 76:518-21. 10.1136\/adc.76.6.518","journal-title":"Arch Dis Child"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-014-2817-4","article-title":"An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome","volume":"29","author":"Johnson S","year":"2014","unstructured":"Johnson S, Stojanovic J, Ariceta G, et al.. An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome. Pediatr Nephrol. 2014, 29:1967-78. 10.1007\/s00467-014-2817-4","journal-title":"Pediatr Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-1594","article-title":"Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome","volume":"133","author":"Diamante Chiodini B","year":"2014","unstructured":"Diamante Chiodini B, Davin JC, Corazza F, Khaldi K, Dahan K, Ismaili K, Adams B. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome. Pediatrics. 2014, 133:e1764-8. 10.1542\/peds.2013-1594","journal-title":"Pediatrics"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-012-1615-y","article-title":"Profound neurological injury in a patient with atypical hemolytic uremic syndrome","volume":"92","author":"Salem G","year":"2013","unstructured":"Salem G, Flynn JM, Cataland SR. Profound neurological injury in a patient with atypical hemolytic uremic syndrome. Ann Hematol. 2013, 92:557-8. 10.1007\/s00277-012-1615-y","journal-title":"Ann Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-013-2416-9","article-title":"Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab","volume":"28","author":"Gulleroglu K","year":"2013","unstructured":"Gulleroglu K, Fidan K, Han\u00e7er VS, Bayrakci U, Baskin E, Soylemezoglu O. Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab. Pediatr Nephrol. 2013, 28:827-30. 10.1007\/s00467-013-2416-9","journal-title":"Pediatr Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome","volume":"33","author":"Kavanagh D","year":"2013","unstructured":"Kavanagh D, Goodship TH, Richards A. Atypical hemolytic uremic syndrome. Semin Nephrol. 2013, 33:508-30. 10.1016\/j.semnephrol.2013.08.003","journal-title":"Semin Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat C","year":"2016","unstructured":"Loirat C, Fakhouri F, Ariceta G, et al.. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2016, 31:15-39. 10.1007\/s00467-015-3076-8","journal-title":"Pediatr Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2013.280","article-title":"Cardiovascular complications in atypical haemolytic uraemic syndrome","volume":"10","author":"Noris M","year":"2014","unstructured":"Noris M, Remuzzi G. Cardiovascular complications in atypical haemolytic uraemic syndrome. Nat Rev Nephrol. 2014, 10:174-80. 10.1038\/nrneph.2013.280","journal-title":"Nat Rev Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-3933-3","article-title":"Extra-renal manifestations of atypical hemolytic uremic syndrome in children","volume":"33","author":"Fidan K","year":"2018","unstructured":"Fidan K, G\u00f6knar N, G\u00fclhan B, et al.. Extra-renal manifestations of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2018, 33:1395-403. 10.1007\/s00467-018-3933-3","journal-title":"Pediatr Nephrol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-012-2276-8","article-title":"Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome","volume":"27","author":"Vilalta R","year":"2012","unstructured":"Vilalta R, Lara E, Madrid A, Chocron S, Mu\u00f1oz M, Casquero A, Nieto J. Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome. Pediatr Nephrol. 2012, 27:2323-6. 10.1007\/s00467-012-2276-8","journal-title":"Pediatr Nephrol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq160","article-title":"Myocardial infarction is a complication of factor H-associated atypical HUS","volume":"25","author":"Sall\u00e9e M","year":"2010","unstructured":"Sall\u00e9e M, Daniel L, Piercecchi MD, Jaubert D, Fremeaux-Bacchi V, Berland Y, Burtey S. Myocardial infarction is a complication of factor H-associated atypical HUS. Nephrol Dial Transplant. 2010, 25:2028-32. 10.1093\/ndt\/gfq160","journal-title":"Nephrol Dial Transplant"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-002-0973-4","article-title":"Peripheral gangrene complicating hemolytic uremic syndrome in a child","volume":"18","author":"Ozel A","year":"2003","unstructured":"Ozel A, Cali\u015fkan U, G\u00fccer S. Peripheral gangrene complicating hemolytic uremic syndrome in a child. Pediatr Nephrol. 2003, 18:465-7. 10.1007\/s00467-002-0973-4","journal-title":"Pediatr Nephrol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.09.020","article-title":"Skin involvement in atypical hemolytic uremic syndrome","volume":"63","author":"Ardissino G","year":"2014","unstructured":"Ardissino G, Tel F, Testa S, Marzano AV, Lazzari R, Salardi S, Edefonti A. Skin involvement in atypical hemolytic uremic syndrome. Am J Kidney Dis. 2014, 63:652-5. 10.1053\/j.ajkd.2013.09.020","journal-title":"Am J Kidney Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s004670050058","article-title":"Peripheral gangrene complicating idiopathic and recessive hemolytic uremic syndromes","volume":"14","author":"Kaplan BS","year":"2000","unstructured":"Kaplan BS, Garcia CD, Chesney RW, Segar WE, Giugno K, Chem R. Peripheral gangrene complicating idiopathic and recessive hemolytic uremic syndromes. Pediatr Nephrol. 2000, 14:985-9. 10.1007\/s004670050058","journal-title":"Pediatr Nephrol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-0903","article-title":"Peripheral gangrene in children with atypical hemolytic uremic syndrome","volume":"131","author":"Malina M","year":"2013","unstructured":"Malina M, Gulati A, Bagga A, Majid MA, Simkova E, Schaefer F. Peripheral gangrene in children with atypical hemolytic uremic syndrome. Pediatrics. 2013, 131:e331-5. 10.1542\/peds.2012-0903","journal-title":"Pediatrics"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-013-2591-8","article-title":"Eculizumab long-term therapy for pediatric renal transplant in aHUS with CFH\/CFHR1 hybrid gene","volume":"29","author":"Rom\u00e1n-Ortiz E","year":"2014","unstructured":"Rom\u00e1n-Ortiz E, Mendizabal Oteiza S, Pinto S, L\u00f3pez-Trascasa M, S\u00e1nchez-Corral P, Rodr\u00edguez de Cordoba S. Eculizumab long-term therapy for pediatric renal transplant in aHUS with CFH\/CFHR1 hybrid gene. Pediatr Nephrol. 2014, 29:149-53. 10.1007\/s00467-013-2591-8","journal-title":"Pediatr Nephrol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006080811","article-title":"Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome","volume":"18","author":"Sellier-Leclerc AL","year":"2007","unstructured":"Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, et al.. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2007, 18:2392-400. 10.1681\/ASN.2006080811","journal-title":"J Am Soc Nephrol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12864","article-title":"Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: The experience of the Australian compassionate access cohort","volume":"45","author":"Mallett A","year":"2015","unstructured":"Mallett A, Hughes P, Szer J, et al.. Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: The experience of the Australian compassionate access cohort. Intern Med J. 2015, 45:1054-65. 10.1111\/imj.12864","journal-title":"Intern Med J"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0808527","article-title":"Eculizumab for atypical hemolytic-uremic syndrome","volume":"360","author":"N\u00fcrnberger J","year":"2009","unstructured":"N\u00fcrnberger J, Philipp T, Witzke O, et al.. Eculizumab for atypical hemolytic-uremic syndrome. N Engl J Med. 2009, 360:542-4. 10.1056\/NEJMc0808527","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2147\/CPAA.S17904","article-title":"Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome","volume":"3","author":"Ohanian M","year":"2011","unstructured":"Ohanian M, Cable C, Halka K. Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome. Clin Pharmacol. 2011, 3:5-12. 10.2147\/CPAA.S17904","journal-title":"Clin Pharmacol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/295323","article-title":"Eculizumab therapy leads to rapid resolution of thrombocytopenia in atypical hemolytic uremic syndrome","volume":"2014","author":"Tsai HM","year":"2014","unstructured":"Tsai HM, Kuo E. Eculizumab therapy leads to rapid resolution of thrombocytopenia in atypical hemolytic uremic syndrome. Adv Hematol. 2014, 2014:295323. 10.1155\/2014\/295323","journal-title":"Adv Hematol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-054536","article-title":"Safety and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome: protocol for a multicentre, open-label, prospective, single-arm study","volume":"12","author":"Dunn S","year":"2022","unstructured":"Dunn S, Brocklebank V, Bryant A, et al.. Safety and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome: protocol for a multicentre, open-label, prospective, single-arm study. BMJ Open. 2022, 12:e054536. 10.1136\/bmjopen-2021-054536","journal-title":"BMJ Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/274826-unprecedented-haemorrhagic-stroke-a-rare-manifestation-of-atypical-haemolytic-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T13:06:20Z","timestamp":1727269580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/274826-unprecedented-haemorrhagic-stroke-a-rare-manifestation-of-atypical-haemolytic-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.70159","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,25]]}}}